An interventional study of I-TEAM in Autism and Early Intervention, sponsored by Seattle Children's Hospital. Status unknown at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-12.
Sponsored by Seattle Children's Hospital · Not applicable, Interventional, and Treatment
Although the efficacy of early intervention (EI) for autistic children and their families has been established, many marginalized families with diverse cultural and linguistic backgrounds still report inequitable access to evidence-based practices (EBP). There are several strategies to increase EBP implementation that are especially relevant to marginalized families who report inequitable access to coaching from EI providers, such as increasing the capacity of EI providers to coach families in a culturally responsive way. However, EI providers are provided with limited professional development in both family coaching and cultural responsiveness, which results in perpetuation of EBP implementation failure. Thus, it is crucial to develop and validate an implementation toolkit that comprises strategies to enhance cultural responsiveness in the uptake of EBPs among EI providers. Therefore, the overall purpose of this research is to identify facilitators and barriers of EBP implementation among marginalized families in EI to aid the development an implementation toolkit with a focus on capacity building of EI providers to implement EBP with cultural responsiveness. This will involve conducting individual interviews with EI providers.
1,360 studies on the registry are indexed under Autistic Disorder; 332 are open to participants now.
This study's enrollment of 40 is below the median of 46 across 1,058 interventional studies indexed under Autistic Disorder.
Browse Autistic Disorder studies →Seattle Children's Hospital is the lead sponsor of 214 studies on the registry; 43 are open to participants now.
Counted across the registry records on this site, refreshed daily.
There are two sets of inclusion criteria for both types of participants.
Inclusion Criteria for EI providers:
Exclusion Criteria for EI providers:
Inclusion Criteria for families:
Exclusion Criteria for EI providers:
Intervention group will receive access to the I-TEAM
Behavioral: I-TEAM
Waitlist control group will not receive access to the I-TEAM until the Intervention group has completed the 8-week intervention.
I-TEAM is a web-based implementation toolkit that supports to enhance cultural responsiveness of EI providers in their EBP delivery with minoritized families of young autistic children
Coaching Fidelity Scale (CFS)
CFS is an observational measure to assess coaching fidelity during an interaction between a coach and a learner
Time frame: Change from baseline at 8 weeks
Cultural Self-Efficacy Scale for Early Interventionists (CSES-EI)
CSES-EI is a 32-item, self-reported measure of cultural self-efficacy of early intervention providers
Time frame: Change from baseline at 8 weeks
Social Validity
We will measure acceptability and feasibility of I-TEAM
Time frame: Change from baseline at 8 weeks
Measure of NDBI Strategy Implementation: Caregiver Change (MONSI-CC)
MONSI-CC is an observational measure that detects changes in caregivers' use of NDBI strategies in early intervention
Time frame: Change from baseline at 8 weeks
Autism-specific parenting self-efficacy
We will use this self-reported tool to assess self-efficacy of parents of young autistic children
Time frame: Change from baseline at 8 weeks
Social validity
We will assess social validity, including satisfaction with their services, reports of cultural responsiveness of their providers, acceptability of early intervention among intervention recipients
Time frame: Change from baseline at 8 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.